Your browser doesn't support javascript.
loading
The Integration of Nanomedicine with Traditional Chinese Medicine: Drug Delivery of Natural Products and Other Opportunities.
Zeng, Muling; Guo, Dongdong; Fernández-Varo, Guillermo; Zhang, Xu; Fu, Siqi; Ju, Shijie; Yang, Huiling; Liu, Xingfei; Wang, Ya-Chao; Zeng, Yu; Casals, Gregori; Casals, Eudald.
Afiliación
  • Zeng M; School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
  • Guo D; School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
  • Fernández-Varo G; Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer de Villarroel, 170, 08036 Barcelona, Spain.
  • Zhang X; Department of Biomedicine, University of Barcelona, 08007 Barcelona, Spain.
  • Fu S; School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
  • Ju S; Department of Dermatology, Second Xiangya Hospital Central South University, Changsha 410011, China.
  • Yang H; School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
  • Liu X; School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
  • Wang YC; School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
  • Zeng Y; The Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China.
  • Casals G; Department of Neurosurgery, Xiangya Hospital Central South University, Changsha 410008, China.
  • Casals E; First Clinical Department of Changsha Medical University, Changsha 410219, China.
Mol Pharm ; 20(2): 886-904, 2023 02 06.
Article en En | MEDLINE | ID: mdl-36563052
ABSTRACT
The integration of progressive technologies such as nanomedicine with the use of natural products from traditional medicine (TM) provides a unique opportunity for the longed-for harmonization between traditional and modern medicine. Although several actions have been initiated decades ago, a disparity of reasons including some misunderstandings between each other limits the possibilities of a truly complementation. Herein, we analyze some common challenges between nanomedicine and traditional Chinese medicine (TCM). These challenges, if solved in a consensual way, can give a boost to such harmonization. Nanomedicine is a recently born technology, while TCM has been used by the Chinese people for thousands of years. However, for these disciplines, the regulation and standardization of many of the protocols, especially related to the toxicity and safety, regulatory aspects, and manufacturing procedures, are under discussion. Besides, both TCM and nanomedicine still need to achieve a wider social acceptance. Herein, we first briefly discuss the strengths and weaknesses of TCM. This analysis serves to focus afterward on the aspects where TCM and nanomedicine can mutually help to bridge the existing gaps between TCM and Western modern medicine. As discussed, many of these challenges can be applied to TM in general. Finally, recent successful cases in scientific literature that merge TCM and nanomedicine are reviewed as examples of the benefits of this harmonization.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Productos Biológicos / Medicamentos Herbarios Chinos Límite: Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Productos Biológicos / Medicamentos Herbarios Chinos Límite: Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA